LC-MS/MS raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-11-22 and is reviewed periodically as new material appears.
Preclinical reports have linked SR9009 to improved endurance and altered energy expenditure in rodents. Such findings have prompted interest in whether REV-ERB activation can influence skeletal muscle metabolism. However, the reported effects depend on dose, route, and experimental model, and replication across laboratories is limited. Human trials have not established comparable outcomes, so claims about exercise performance remain speculative. The absence of controlled human data is a central limitation in interpreting these observations.
The mechanism of action involves binding to REV-ERB receptors and recruiting corepressor complexes, which represses target gene transcription. This contrasts with many nuclear receptor agonists that activate transcription. Downstream effects may include changes in autophagy, mitochondrial biogenesis, and lipid handling, but the precise pathways remain an active area of study. Whether these molecular events translate into meaningful physiological effects in humans is unresolved. Most evidence comes from cultured cells and rodent models rather than human participants.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic REV-ERB agonist | Small molecule; not a steroid or peptide. |
| Primary targets | NR1D1 and NR1D2 | Also known as REV-ERBα and REV-ERBβ. |
| Studied routes | Intraperitoneal in rodents | Oral bioavailability in humans is not established. |
| Human approval | No approved therapeutic indication | No recognized clinical use. |
| Key uncertainty | Human physiological effects | Preclinical findings may not translate. |
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. These receptors help regulate circadian rhythms, lipid metabolism, and inflammatory gene expression. In cell and animal experiments, SR9009 alters transcription of clock-controlled genes and metabolic pathways. The compound is not a hormone and does not resemble classical steroid structures. Its activity depends on binding to the ligand-binding domain of REV-ERB, where it can modify corepressor recruitment.
Research interest in SR9009 grew from studies of circadian biology and metabolic disease. Preclinical reports describe effects on exercise capacity, muscle metabolism, and blood lipid levels in rodents, but these findings come from controlled laboratory settings. The compound has low oral bioavailability in animals, which limits systemic exposure after swallowing. Investigators often use injected routes in experiments to achieve measurable plasma concentrations. Human clinical data are sparse, no approved therapeutic product exists, and whether animal effects translate to humans remains an open question.
Regulatory and sporting contexts treat SR9009 as a prohibited substance in many elite competitions. Its presence on banned lists reflects concerns about performance enhancement and unknown long-term safety. Analytical chemists have developed methods to detect the parent compound and its metabolites in urine and blood. Literature discussions distinguish between in vitro potency, animal pharmacology, and anecdotal human reports. The latter are difficult to verify because products sold online may lack purity or contain different compounds.
== Distribution == The principal factor controlling the distribution of aquatic plants is the availability of water. However, other abiotic factors may also control their distribution including nutrient availability, availability of carbon dioxide and oxygen, water temperature, characteristics of the substrate, water transparency, water movement, and salinity. Some aquatic plants are able to thrive in brackish, saline, and salt water. Also biotic factors like grazing, competition for light, colonization by fungi, and allelopathy are influencing the occurrence of macrophytes.
=== 1918 uprisings === In mid-1918, the Union moved from underground organization to open insurrection. It played a central role in organizing a series of anti-Bolshevik uprisings, most notably in Yaroslavl, but also in Rybinsk, Murom, and Elatma. These uprisings formed part of a broader effort to ignite coordinated resistance against the Bolshevik government. Additional revolts were reportedly planned in Moscow and Kazan, but arrests of members of the organization in May 1918 disrupted these plans before they could be carried out. The uprisings were suppressed by Soviet forces, and the Union's operational structure inside Russia was effectively broken apart in the aftermath.
He played for Queens Park Rangers and Manchester United. Gemma Ray, musician, singer, composer and producer, raised in Billericay Charlie Richardson, gangster, lived in Billericay Stewart Robson, footballer, born in Billericay Joseph Thornton, 19th-century Oxford-based bookseller, born in Billericay Russell Tovey, actor, has Billericay as his home town Paul Walter, cricketer, born in Billericay Patrick W. Welch, painter, born in Billericay Charlie Wernham, comedian and comedy actor, born and lives in Billericay Ben Wheatley, film director, born in Billericay.
Sources: en.wikipedia.org
== Cleaning up oil spills == The U.S. Environmental Protection Agency (EPA) documents more than ten thousand oil spills per year. Conventionally, biological, dispersing, and gelling agents are deployed to remedy oil spills. Although, these methods have been used for decades, none of these techniques can retrieve the irreplaceable lost oil. However, nanowires can not only swiftly clean up oil spills but also recover as much oil as possible. These nanowires form a mesh that absorbs up to twenty times its weight in hydrophobic liquids while rejecting water with its water repelling coating. Since the potassium manganese oxide is very stable even at high temperatures, the oil can be boiled off the nanowires and both the oil and the nanowires can then be reused. In 2005, Hurricane Katrina damaged or destroyed more than thirty oil platforms and nine refineries. The Interface Science Corporation successfully launched a new oil remediation and recovery application, which used the water repelling nanowires to clean up the oil spilled by the damaged oil platforms and refineries.
They are also sufficiently common that "passage" birds in their first year are relatively easy to trap. Wild-caught kestrels "tame down" fairly quickly. They will usually be eating from a falconer's hand the day after capture, be training within a week, and be ready to hunt in three to five weeks. A very tame American kestrel will allow itself to be picked up around the body with one hand while accepting tidbits from the other hand. Such tameness is very useful when checking or treating the bird for injury or illness. Migratory raptors native to the United States are protected by the Migratory Bird Treaty Act of 1918, so American kestrels are illegal to possess without a permit (such as a falconry permit) in the United States, Canada, and Mexico.
=== Bosnia and Herzegovina, Croatia, Montenegro, Serbia, Macedonia === "Pola pola" ("half and half") is a slang term for the drink spritzer, made out of equal parts of white wine or rosé wine and carbonated water. Different ratios of wine and carbonated water are named with various slang terms, depending on the region. "Pola pola" is also known as "litra i voda" (one bottle of wine and one bottle of carbonated water), as well as "Litar-litar" (as in 1 liter of wine, 1 liter of water) and "Gemišt".
The relationship between pressure and volume was first noted by Richard Towneley and Henry Power in the 17th century. Robert Boyle confirmed their discovery through experiments and published the results. According to Robert Gunther and other authorities, it was Boyle's assistant, Robert Hooke, who built the experimental apparatus. Boyle's law is based on experiments with air, which he considered to be a fluid of particles at rest in between small invisible springs. Boyle may have begun experimenting with gases due to an interest in air as an essential element of life; for example, he published works on the growth of plants without air. Boyle used a closed J-shaped tube and after pouring mercury from one side he forced the air on the other side to contract under the pressure of mercury. After repeating the experiment several times and using different amounts of mercury he found that under controlled conditions, the pressure of a gas is inversely proportional to the volume occupied by it. The French physicist Edme Mariotte (1620–1684) discovered the same law independently of Boyle in 1679, after Boyle had published it in 1662. Mariotte did, however, discover that air volume changes with temperature. Thus this law is sometimes referred to as Mariotte's law or the Boyle–Mariotte law.
Sources: en.wikipedia.org
It is a synthetic compound that acts as an agonist at REV-ERBα and REV-ERBβ. It is used mainly as a research chemical to study circadian and metabolic pathways. It is not approved for human therapeutic use.
REV-ERB receptors generally repress transcription when bound by natural heme. SR9009 is described as an agonist that enhances this repressive activity. The result is altered expression of clock and metabolic genes.
Published controlled human trials are lacking. Some sources cite limited or unofficial reports, but these do not establish safety or efficacy. Claims about human performance effects remain unverified.
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.